Skip to main content
Retour
SION logo

Sionna Therapeutics, Inc.

Qualité des données : 100%
SION
NASDAQ Healthcare Biotechnology
36,43 €
▲ 0,04 € (0,11%)
Cap. Boursière : 1,64B
Fourchette du Jour
35,64 € 38,29 €
Fourchette 52 Semaines
7,26 € 45,00 €
Volume
341 100
Moyenne 50J / 200J
38,16 € / 30,86 €
Clôture Précédente
36,39 €

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Healthcare (626 pairs)

Métrique Action Médiane du Secteur
P/E -21,8 0,4
P/B 5,3 2,9
ROE % -105,2 3,7
Net Margin % 3,8
Rev Growth 5Y % 10,0
D/E 0,0 0,2

Points Clés

Debt/Equity of 0,03 — conservative balance sheet
Negative free cash flow of -66,67M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-105,18%
ROIC-21,15%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
0,03
Current Ratio20,61
Interest Coverage0,00

Valorisation

P/E Ratio
-21,78
P/B Ratio5,34
EV/EBITDAN/A
Dividend Yield0,00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0,0 Net Income (TTM) -75,27M
ROE -105,18% ROA -23,09%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -66,67M
ROIC -21,15% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,03 Current Ratio 20,61
Interest Coverage 0,00 Dividend Yield 0,00%
Valuation
P/E Ratio -21,78 P/B Ratio 5,34
P/S Ratio N/A PEG Ratio -0,64
EV/EBITDA N/A Dividend Yield 0,00%
Market Cap 1,64B Enterprise Value 1,59B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Revenue 0,0 0,0 0,0 0,0
Net Income -75,27M -61,69M -47,26M -40,24M
EPS (Diluted) -1,88 -1,40 -1,07 -0,91
Gross Profit -647 000,0 -668 000,0 0,0 0,0
Operating Income -88,98M -70,56M -50,33M -41,37M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Total Assets 325,95M 185,75M 51,95M 87,37M
Total Liabilities 19,12M 349,47M 166,83M 157,29M
Shareholders' Equity 306,83M -163,71M -114,88M -69,92M
Total Debt 8,68M 9,75M 10,48M 0,0
Cash & Equivalents 58,45M 37,79M 38,52M 54,84M
Current Assets 241,42M 150,99M 39,21M 83,83M
Current Liabilities 11,71M 10,42M 8,04M 8,25M